Distalmotion has been granted De Novo approval by the US Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult inguinal hernia repair.
This significant milestone marks another step forward in Distalmotion’s mission to empower robotic surgery excellence by expanding access and improving care with robotic assisted surgery in the hospital outpatient and ambulatory surgery centers (ASC’s) where over 90 percent of inguinal hernia repairs are currently performed in the United States.
With more than 1,300 patients successfully treated in Europe, Distalmotion’s extensive experience has paved the way for bringing this innovation to the US market. [Read more…] about US FDA grants authorization for Distalmotion surgical robot